Alaunos Therapeutics, Inc. (TCRT): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2016-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$290.0K
Year ended 2016-12-31
-26.8%
3-year compound annual growth
+1.6%
5-year compound annual growth
$738.0K2009-12-31: $330.0K2010-12-31: $188.0K2011-12-31: $268.0K2012-12-31: $658.0K2013-12-31: $738.0K2014-12-31: $462.0K2015-12-31: $357.0K2016-12-31: $290.0K$290.0K
2009-12-31 Depreciation & Amortization (USD) 2016-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2016-12-31$290.0K-18.8%2017-02-16, From 2016-01-01
2015-12-31$357.0K-22.7%2017-02-16, From 2015-01-01
2014-12-31$462.0K-37.4%2017-02-16, From 2014-01-01
2013-12-31$738.0K+12.2%2016-02-24, From 2013-01-01
2012-12-31$658.0K+145.5%2015-02-26, From 2012-01-01
2011-12-31$268.0K+42.6%2014-03-03, From 2011-01-01
2010-12-31$188.0K-43.0%2013-03-18, From 2010-01-01
2009-12-31$330.0Kn/a2012-02-29, From 2009-01-01